Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

NEW YORK (Reuters) - Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty ...

Shares of consumer-products company Kenvue Inc. rose the most in more than two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

Wall Street tipped toward losses before the open on Monday as markets gird for another busy week of corporate earnings ...

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

Wall Street tipped toward losses before the open as markets gird for another busy week of corporate earnings reports. Futures ...

Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge.

This outperformance is showing up in markets, too. They noted the spread between one-year forward rates in the U.S. and the Eurozone has widened 60 basis points over the last month, as the dollar ...